A reactive oxygen-generating system activates nuclear factor-κB and releases tumor necrosis factor-α in coronary smooth muscle cells

Journal of Surgical Research

Volumn 85, Issue 1, 1999, Pages 142-147

  Newman, Walter H ^a   Zunzunegui, Raul G ^a   Warejcka, Debra J ^a   Dalton, Martin L ^a   Castresana, Manuel R ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

NF B; Oxygen radicals; Smooth muscle cells; TNF

Indexed keywords

HYPOXANTHINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; XANTHINE OXIDASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; ELECTROPHORETIC MOBILITY; GENE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; SWINE; VASCULAR SMOOTH MUSCLE;

EID: 0032786527     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5668     Document Type: Article

References (45)

1. Basaran Y., Basaran M. M., Babacan K. F., Ener B., Okay T., Gok H., Ozdemir M. Serum tumor necrosis factor levels in acute myocardial infarction and unstable angina pectoris. Angiology. 44:1993;332.
2. Latini R., Bianchi M., Correale E., Dinarello C. A., Fantuzzi G., Fresco C., Maggioni A. P., Mengozzi M., Romano S., Shapiro L., Sironi M., Tognoni G., Turato R., Ghezzi P. Cytokines in acute myocardial infarction: Selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin-1 receptor antagonist. J. Cardiovasc. Pharmacol. 23:1994;1.
3. Maury C. P. J., Teppo A.-M. Circulating tumour necrosis factor-α (cachectin) in myocardial infarction. J. Intern. Med. 225:1989;333.
4. Hirschl M. M., Gwechenberger M., Binder T., Binder M., Graf S., Stefenelli T., Rauscha F., Laggner A. N., Sochor H. Assessment of myocardial injury by serum tumor necrosis factor alpha measurements in acute myocardial infarction. Eur. Heart J. 17:1996;1852.
5. Lissoni P., Pelizzoni F., Mauri O., Perego M., Pittalis S., Barni S. Enhanced secretion of tumor necrosis factor in patients with myocardial infarction. Eur. J. Med. 1:1992;277.
6. Biasucci L. M., Vitelli A., Liuzzo G., Altamura S., Caligiuri G., Monaco C., Rebuzzi A. G., Ciliberto G., Maseri A. Elevated levels of interleukin-6 in unstable angina. Circulation. 94:1996;874.
7. Neumann F.-J., Ott I., Gawaz M., Richardt G., Holzapfel H., Jochum M., Schomig A. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation. 92:1995;748.
8. Tashiro H., Shimokawa H., Yamamoto K., Nagano M., Momohara M., Muramatu K., Takeshita A. Monocyte-related cytokines in acute myocardial infarction. Am. Heart J. 130:1995;446.
9. Wan S., DeSmet J.-M., Barvais L., Goldstein M., Vincent J.-L., LeClerc J.-L. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J. Thoracic Cardiovasc. Surg. 112:1996;806.
10. Hennein H. A., Ebba H., Rodriguez J. L., Merrick S. H., Keith F. M., Bronstein M. H., Leung J. M., Mangano D. T., Greenfield L. J., Rankin J. S. Relationship of proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J. Thoracic Cardiovasc. Surg. 108:1994;626.
11. Meldrum H.A., Meng X., Dinarello C.A., Ayala A., Cain B.S., Shames B. D., Ao L., Banerjee A., Harken A. H. Human myocardial tissue TNFα expression following acute global ischemia in vivo. J. Mol. Cell Cardiol. 30:1998;1683.
12. Ashraf M., Zhai X. Pathophysiology of myocardial reperfusion injury: Role of oxygen free radicals. Transplant. Proc. 27:1995;2800.
13. Ferrari R., Agnoletti L., Comini L., Gaia G., Bachetti T., Cargnoni A., Ceconi C., Curello S., Visioli O. Oxidative stress during myocardial ischemia and heart failure. Eur. Heart J. 19:1998;B2.
14. Hansen P. R. Myocardial reperfusion injury: Experimental evidence and clinical relevance. Eur. Heart J. 16:1995;734.
15. McCord J. M. Oxygen derived free radicals in postischemic tissue injury. N. Engl. J. Med. 312:1985;159.
16. Chaudhri G., Clark I. A. Reactive oxygen species facilitate the in vitro and in vivo lipopolysaccharide-induced release of tumor necrosis factor. J. Immunol. 143:1989;1290.
17. Schwartz M. D., Repine J. E., Abraham E. Xanthine oxidase-derived oxygen radicals increase lung cytokine expression in mice subjected to hemorrhagic shock. Am. J. Respir. Cell Mol. Biol. 12:1995;434.
18. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12:1993;2005.
19. Schmidt K. N., Amstad P., Cerutti P., Baeuerle P. A. Identification of hydrogen peroxide as the relevant messenger in the activation of transcription factor NF-κB. Adv. Exp. Med Biol. 387:1996;63.
20. Muller J. M., Rupec R. A., Baeuerle P. A. Study of gene regulation by NF-κB and AP-1 in response to reactive oxygen intermediates. Methods Companion Methods Enzymol. 11:1997;301.
21. Blackwell T. S., Christman J. W. The role of nuclear factor-κB in cytokine gene regulation. Am. J. Respir. Cell Mol. Biol. 17:1997;3.
22. Meldrum D. R., Dinarello C. A., Cleveland J. C., Cain B. S., Shames B. D., Meng X., Harken A.H. Hydrogen peroxide induces tumor necrosis factor α-mediated cardiac injury by a P38 mitogen-activated protein kinase-dependent mechanism. Surgery. 124:1998;291.
23. Chandrasekar B., Freeman G. L. Induction of nuclear factor κB and activation protein 1 in postischemic myocardium. FEBS Lett. 410:1997;30.
24. Meldrum D. R., Shenkar R., Sheridan B. C., Cain B. S., Abraham E., Harken A. H. Hemorrhage activates myocardial NF-κB and increases TNF-α in the heart. J. Mol. Cell. Cardiol. 29:1997;2849.
25. Newman W. H., Zhang L. M., Lee D. H., Dalton M. L., Warejcka D. J., Castresana M. R., Leeper-Woodford S. K. Release of tumor necrosis factor-α from coronary smooth muscle: Activation of NF-κB and inhibition by elevated cyclic AMP. J. Surg. Res. 80:1998;129.
26. Zhang L. M., Castresana M. R., Stefansson S., Newman W. H. Tolerance to sodium nitroprusside: Studies in cultured porcine vascular smooth muscle cells. Anesthesiology. 79:1993;1094.
27. Newman W. H., Zhang L. M., McDonald M. H., Jolow D. J., Castresana M. R. Tolerance to nitroglycerin in vascular smooth muscle cells is not affected by the level of intracellular glutathione or l-cysteine. Anesth. Analg. 81:1995;1229.
28. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:1976;248.
29. Flick D. A., Gifford G. E. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J. Immunol. Methods. 68:1984;167.
30. Skalli O., Ropraz P., Trzeciak A., Benzonznz G., Gillessen D., Gabbiani G. A monoclonal antibody against α-smooth muscle actin: A new probe for smooth muscle differentiation. J. Cell. Biol. 103:1986;2787.
31. Hoyer L. W., de los Santos R. P., Hoyer J. R. Antihemophilic factor antigen: Localization in endothelial cells by immunofluorescent microscopy. J. Clin. Invest. 52:1973;2737.
32. Lawrence R., Chang L.-J., Siebenlist U., Bressler P., Sonenshein G. Vascular smooth muscle cells express a constitutive NF-κB-like activity. J. Biol. Chem. 269:1994;28913.
33. Newman W. H., Zhang L. M., Leeper-Woodford S. K., Shaker I. J., Erceg S. K., Castresana M. R. Inhibition of release of tumor necrosis factor alpha from human vascular tissue and smooth muscle cells by glucocorticoids. Crit. Care Med. 25:1997;519.
34. Zhang L. M., Leeper-Woodford S. K., Shaker I. J., Dalton M. L., Castresana M. R., Newman W. H. Elevated intracellular cyclic AMP inhibits release of tumor necrosis factor alpha from human vascular tissue and cultured smooth muscle cells. Crit. Care Med. 25:1997;1855.
35. Warner S. J. C., Libby P. Human vascular smooth muscle cells: Target for and source of tumor necrosis factor. J. Immunol. 142:1989;100.
36. Meldrum D. R., Cleveland J. C., Cain B. S., Meng X., Harken A. D. Increased myocardial tumor necrosis factor-α in a crystalloid-perfused model of cardiac ischemia-reperfusion injury. Ann. Thoracic Surg. 65:1998;439.
37. Gurevitch J., Frolkis I., Yuhas Y., Paz Y., Matsa M., Mohr R., Yakirevich Y. Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion. J. Am. Coll. Cardiol. 28:1996;247.
38. Squadrito F., Altavilla D., Zingarelli B., Ioculano M., Calapai G., Campo G. M., Miceli A., Caputi A. P. Tumor necrosis factor involvement in myocardial ischemia-reperfusion injury. Eur. J. Pharmacol. 237:1993;223.
39. Meldrum D. R., Dinarello C. A., Shames B. D., Cleveland J. C., Cain B. S., Banerjee A., Meng X., Harken A. H. Ischemic preconditioning decreases postischemic myocardial tumor necrosis factor-α production. Circulation. 98:1998;II-214.
40. Herskowitz A., Choi S., Ansari A. A., Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium. Am. J. Pathol. 146:1995;419.
41. Chendrasekar B., Streitman J. E., Colston J. T., Freeman G. L. Inhibition of nuclear factor κB attenuates proinflammatory cytokine and inducible nitric-oxide synthase expression in postischemic myocardium. Biochim. Biophys. Acta. 1406:1998;91.
42. Shames B. D., Meldrum D. R., Selzman C. H., Pulido E. J., Cain B. S., Nanerjee A., Harken A. H., Meng X. Increased levels of myocardial IκB-α protein promote tolerance to endotoxin. Am. J. Physiol. 275:1998;H1084.
43. Ono K., Matsumori A., Shioi T., Furukawa Y., Sasayama S. Cytokine gene expression after myocardial infarction in rat hearts: Possible implication in left ventricular remodeling. Circulation. 98:1998;149.
44. Meldrum D. R. Tumor necrosis factor in the heart. Am. J. Physiol. 274:1998;R577.
45. Mehta J. L., Saldeen T. G. P., Rand K. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J. Am. Coll. Cardiol. 31:1998;1217.